Abstract
Efforts of social scientists to understand how individuals living in a family at risk for a genetically linked condition make health care decisions, having brought to the forefront the contextual nature of risk perception. Using a grounded theory approach, this study examines the experiences of 29 individuals living in families at risk for arrhythmogenic right ventricular cardiomyopathy (ARVC). Attention is paid to how individuals (re)construct the meaning of being at risk in relation to the developing science of gene discovery. Findings highlight that individuals living in a family at risk for ARVC juxtapose existing scientific knowledge against experiential knowledge as they “awaken to” the fact that they or a family member are at risk. This process is pragmatic and fluid and contingent upon whether and how symptoms are aligned with the constructed image of the at-risk relative.
This is a preview of subscription content, access via your institution.
References
Ahmad F, Duanxiang LI, Karibe A et al (1998) Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 98:2791–2795. doi:10.1161/01.CIR.98.25.2791
Angus J, Evans S, Lapum J, Rukholm E, St.Onge R, Nolan R, Michel I (2005) “Sneaky disease”: the body and health knowledge for people at risk for coronary heart disease in Ontario, Canada. Soc Sci Med 60:2117–2128. doi:10.1016/j.socscimed.2004.08.069
Binedell J, Soldan JR, Harper PS (1998) Predictive testing for Huntington’s disease: predictors of uptake in south wales. Clin Genet 54:477–88
Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S (2004) Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst 96:122–133. doi:10.1093/jnci/djh017
Brorsson A, Troein M, Lindbladh E, Selander S, Widlund M, Rastam L (1995) My family dies from heart attacks. How hypercholesterolaemic men refer to their family history. Fam Pract 12:433–437. doi:10.1093/fampra/12.4.433
Brunger F, Bassett K (1998) Culture, ethnicity and genetic testing. In: Knoppers BM (ed) Socio-ethical issues in human genetics. Les Éditions Yvon Blais, Quebec
Cameron LD, Sherman S, Marteau T, Brown P (2009) Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol 28:307–16. doi:10.1037/a0013947
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Scinces and Humanities Research Council of Canada, Tri-council policy statement: ethical conduct for research involving humans, December 2010
Chan CW, Lopez V, Chung JW (2011) A qualitative study of the perceptions of coronary heart disease among Hong Kong Chinese people. J Clin Nurs 20:1151–1159. doi:10.1111/j.1365-2702.2010.03526.x
Cox SM (2003) Stories in decisions: how at-risk individuals decide to request predictive testing for Huntington disease. Qual Sociol 26:257–280
Cox SM, McKellin W (1999) There’s this thing in our family’: predictive testing and the construction of risk for Huntington disease. Sociology of Health and Illness 21:622–646. doi:10.1111/1467-9566.00176
d’Agincourt-Canning L (2005) The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns 14:55–69. doi:10.1007/s10897-005-1500-0
Davison C, Frankel S, Smith GD (1989) Inheriting heart trouble: the relevance of common-sense ideas to preventive measures. Health Educ Res 4:329–340. doi:10.1093/her/4.3.329
Davison C, Smith GD, Frankel S (1991) Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education. Sociol Health Illn 13:1–19. doi:10.1111/j.1467-9566.1991.tb00085.x
Davison C, Frankel S, Smith GD (1992) The limits of lifestyle: re-assessing ‘fatalism’ in the popular culture of illness prevention. Soc Sci 34:675–85. doi:10.1016/0277-9536(92)90195-V
Emslie C, Hunt K, Watt G (2001) Invisible women? The importance of gender in lay beliefs about heart problems. Sociol Health Illn 23:203–233. doi:10.1111/1467-9566.00248
Etchegary H (2006a) Discovering the family history of Huntington disease (HD). J Genet Couns 15:105–117. doi:10.1007/s10897-006-9018-7
Etchegary H (2006b) Genetic testing for Huntington’s disease: how is the decision taken? Genet Test 10:60–67. doi:10.1089/gte.2006.10.60
Etchegary H (2009) Coping with genetic risk: living with Huntington disease (HD). Curr Psychol 28:284–301. doi:10.1007/s12144-009-9061-2
Etchegary H (2010) I put it on the back burner most days’: living with chronic risk. Health 15:633–649. doi:10.1177/1363459310364162
Etchegary H, Perrier C (2007) Information processing in the context of genetic risk: implications for genetic-risk communication. J Genet Couns 16:419–432. doi:10.1007/s10897-006-9082-z
Farrimond H, Paula MS, Qureshi N, Philip HE (2010) Making sense of being at ‘high risk’ of coronary heart disease within primary prevention. Psychology 25:289–304. doi:10.1080/08870440802499382
Finkler K (2001) The kin of the gene: The medicalization of family and kinship in American society. Current Anthropology 4: 235–263. Retrieved from http://www.jstor.org/stable/10.1086/320004
Finkler K (2005) Family, kinship, memory and temporality in the age of the new genetics. Soc Sci Med 61:1059–1071. doi:10.1016/j.socscimed.2005.01.002
Frich JC, Ose L, Malterud K, Fugelli P (2006) Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study. Ann Fam Med 4:198–204. doi:10.1370/afm.529
Glaser BG (1978) Theoretical sensitivity. Sociology Press, Mill Valley
Glaser BG, Strauss AL (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, New York
Gollob MH, Blier L, Brugada R et al (2011) Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol 27:232–245. doi:10.1016/j.cjca.2010.12.078
Hall R, Saukko PM, Evans PH, Qureshi N, Humphries SE (2007) Assessing family history of heart disease in primary care consultations: a qualitative study. Fam Pract 24:435–442. doi:10.1093/fampra/cmm037
Hallowell N, Arden-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C (2006) Guilt, blame and responsibility: men’s understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociol Health 28:969–988. doi:10.1111/j.1467-9566.2006.00515.x
Hodgkinson K, Dicks E, Connors S, Young T-L, Parfrey P, Pullman D (2009) Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: lessons for health policy in genetic disease. Genet Med 11:859–865. doi:10.1097/GIM.0b013e3181c20bb3
Hunt K, Davison C, Emslie C, Ford G (2000) Are perceptions of a family history of heart disease related to health-related attitudes and behaviour? Health Educ Res 15:131–143. doi:10.1093/her/15.2.131
Hunt K, Emslie C, Watt G (2001) Lay constructions of a family history of heart disease: potential for misunderstandings in the clinical encounter? Lancet 357:1168–1171. doi:10.1016/S0140-6736(00)04334-8
Katapodi MC, Lee KA, Facione NC, Dodd MJ (2004) Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38:388–402. doi:10.1016/j.ypmed.2003.11.012
Kenen R, Ardern-Jones A, Eeles R (2003) Family stories and the use of heuristics: women from suspected hereditary breast and ovarian cancer (HBOC) families. Sociol Health Illn 25:838–865. doi:10.1046/j.1467-9566.2003.00372.x
Lupton D (1999) Risk and sociocultural theory: new directions and perspectives. Cambridge University Press, New York
Manuel A, Brunger F (2014) Making the decision to participate in predictive genetic testing for arrhythmogenic right ventricular cardiomyopathy. J Genet Couns 23:1045–1055. doi:10.1007-014-9733-4
Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y (1982) Right ventricular dysplasia: a report of 24 cases. Circulation 65:384–398. doi:10.1007/s10897-014-9733-4
Marteau T, Kinmonth A, Pyke S, Thompson S (1995) Readiness for lifestyle advice: self-assessments of coronary risk prior to screening in the British family heart study. Family heart study group. Br J Gen Pract 45:5–8
McAllister M (2002) Predictive genetic testing and beyond: a theory of engagement. J Health Psychol 7:491–505. doi:10.1177/1359105302007005628
McAllister M (2003) Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 64:179–189. doi:10.1034/j.1399-0004.2003.00133.x
Merner ND, Hodgkinson KA, Haywood AFM et al (2008) Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 82:809–821. doi:10.1016/j.ajhg.2008.01.010
Norris J, Spelic S, Snyder C, Tinley S (2009) Five families living with hereditary breast and ovarian cancer risk. Clin J Oncol Nurs 13:73–80. doi:10.1188/09.CJON. 73-80
Ponder M, Lee J, Green J, Richards M (1996) Family history and perceived vulnerability to some common diseases: a study of young people and their parents. J Med Genet 33:485–92. doi:10.1136/jmg.33.6.485
Rahman P, Jones A, Curtis J, Bartlett S, Peddle L, Fernandez BA, Freimer NB (2003) The Newfoundland population: a unique resource for genetic investigation of complex disease. Hum Mol Genet 12:R167–R172. doi:10.10093/hmg/ddg257
Senior V, Smith JA, Michie S, Marteau TM (2002) Making sense of risk: an interpretative phenomenological analysis of vulnerability to heart disease. J Health Psychol 7:157. doi:10.1177/1359105302007002455
Shedlosky-Shoemaker R, Tho LN, Amy KF, Porter K, Leventhal H, Kimberly MK (2010) Exploring perceptions of genetic testing: an examination of perceived accuracy over time. Patient Educ Couns 78:34–39. doi:10.1016/j.pec.2009.05.010
Shiloh S, Saxe L (1989) Perception of risk in genetic counseling. Psychol Health 3:45–61. doi:10.1080/08870448908400365
Sivell S, Elwyn G, Clara LG, Angus JC, Iredale R, Shaw C (2008) How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Couns 17:30–63. doi:10.1007/s10897-007-9132-1
Smith JA, Michie S, Stephenson M, Quarrell O (2002) Risk perception and decision-making processes in candidates for genetic testing for Huntington’s disease: an interpretative phenomenological analysis. J Health Psychol 7:131–144. doi:10.1177/1359105302007002398
Taylor SD (2005) Predictive genetic test decisions for Huntington’s disease: elucidating the test/no-test dichotomy. J Health Psychol 10:597–612. doi:10.1177/1359105305053442
teRijdt WP, Jongbloed JDH, deBoer RA, Theine G, Basso C, van den Berg MP, van Tintelen P (2014) Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC). Eur J Hum Genet 22:e1–e4. doi:10.1038/ejhg.2013.124
Thiene G, Corrado D, Basso C (2007) Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis 2:1–16. doi:10.1186/1750-1172-2-45
van Maarle MC, Southard ME, Boonsel GJ (2003) Risk perception of participants in a family-based genetic screening program on familial hypercholesterolemia. Am J Med Genet 116A:136–143. doi:10.1002/ajmg.a.10061
Walter FM, Emery J (2005) ‘Coming down the line’—patients’ understanding of their family history of common chronic disease. Ann Fam Med 3:405–414. doi:10.1370/afm.368
Walter FM, Emery J, Braithwaite D, Marteau TM (2004) Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med 2:583–595. doi:10.1370/afm.242
Weiner K (2009) The tenacity of the coronary candidate: how people with familial hypercholesterolaemia construct raised cholesterol and coronary heart disease. Health 13:407–427. doi:10.1177/1363459309103915
Weiner K, Durrington P (2008) Patients’ understandings and experiences of familial hypercholesterolemia. Community Genet 11:273–282. doi:10.1159/000121398
Acknowledgments
Authors would like to thank all of the participants, Dr. Kathy Hodgkinson, Dr. Shirley Solberg, Dr. Diana Gustafson, Genome Atlantic and the Provincial Medical Genetics Clinic, NL.
Conflict of interest
April Manuel and Fern Brunger declare that they have no conflict of interest.
Compliance with ethical guidelines
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with Helsinki Declaration of 1975, as revised in 2000(5). Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manuel, A., Brunger, F. “Awakening to” a new meaning of being at-risk for arrhythmogenic right ventricular cardiomyopathy: a grounded theory study. J Community Genet 6, 167–175 (2015). https://doi.org/10.1007/s12687-015-0212-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-015-0212-x